Sign in

CIK 0001819133

  • Non-accelerated filer
  • Smaller reporting company

Tango Therapeutics, Inc.

Sign in to watch
Ticker
TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-320-4900
Business address
201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
Former names
BCTG Acquisition Corp.
  1. 4 Grant or award Director acquired 5,000 shares (grant or award)
  2. 4 Grant or award Director acquired 5,000 shares (grant or award)
  3. 4 Grant or award Director acquired 5,000 shares (grant or award)
  4. 4 Grant or award Director acquired 5,000 shares (grant or award)
  5. 4 Grant or award Crystal Adam acquired 81,250 shares (grant or award)
  6. 4 Grant or award Chief Executive Officer acquired 89,545 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 32,842 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award General Counsel acquired 23,898 shares (grant or award)
  10. 4 Grant or award Chief Scientific Officer acquired 31,697 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy 10% owner bought 237,000 shares at an average $4.41 ($1,044,573)
  14. 4 Open-market buy 10% owner bought 182,000 shares at an average $3.92 ($714,096)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 8 · 156 filings